Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions	Overall Response Rate	Recruiting	Phase 2	2025-07-29		NCT07090525

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Qingdao Central Hospital	10

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Qingdao Central Hospital	Qingdao	China	5

Clinical trials